The aim of this study was therefore to determine the effects of doxorubicin on apoptosis signalling, autophagy, the MAPK- and PI3K/Akt signalling pathway, cell cycle control, and regulators of the EMT process in murine breast cancer tumours. The gene discussed is AKT1; the disease is breast carcinoma.